Eleonora Arboscello
- Cardiology and Cardiovascular Medicine top 10%
- Oncology
- Pulmonary and Respiratory Medicine
- Radiology, Nuclear Medicine and Imaging
- Hematology top 10%
- Co-authors
- Paolo SpallarossaMatteo SarocchiPietro AmeriClaudio BrunelliGiacomo TiniG GhigliottiFrancesco GrossiGiuseppina Novo
- Topics
- Chemotherapy-induced cardiotoxicity and mitigation (12 papers)Cancer Treatment and Pharmacology (6 papers)Cancer Immunotherapy and Biomarkers (5 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Eleonora Arboscello
41 papers receiving 526 citations
Peers
Comparison fields: 5 of 74
- Cardiology and Cardiovascular Medicine 237
- Oncology 210
- Pulmonary and Respiratory Medicine 83
- Radiology, Nuclear Medicine and Imaging 81
- Hematology 74
Countries citing papers authored by Eleonora Arboscello
This map shows the geographic impact of Eleonora Arboscello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleonora Arboscello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleonora Arboscello more than expected).
Fields of papers citing papers by Eleonora Arboscello
This network shows the impact of papers produced by Eleonora Arboscello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleonora Arboscello. The network helps show where Eleonora Arboscello may publish in the future.
Co-authorship network of co-authors of Eleonora Arboscello
This figure shows the co-authorship network connecting the top 25 collaborators of Eleonora Arboscello. A scholar is included among the top collaborators of Eleonora Arboscello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleonora Arboscello. Eleonora Arboscello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 18 | |
| 3 | 7 | |
| 4 | 22 | |
| 5 | 26 | |
| 6 | 51 | |
| 7 | 8 | |
| 8 | 43 | |
| 9 | 13 | |
| 10 | 24 | |
| 11 | 1 | |
| 12 | 39 | |
| 13 | 10 | |
| 14 | 16 | |
| 15 | 25 | |
| 16 | 20 | |
| 17 | In vitro toxicity of taxol based anticancer drug combinations on human hemopoietic progenitors. | 6 |
| 18 | Toxicity on human hemopoietic progenitors of 2'-2'-difluoro-2'deoxycytidine (gemcitabine). | 1 |
| 19 | 1 | |
| 20 | 1 |
About Eleonora Arboscello
Eleonora Arboscello is a scholar working on Critical Care and Intensive Care Medicine, Hematology and Genetics, having authored 44 papers that have together received 534 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (12 papers), Cancer Treatment and Pharmacology (6 papers) and Cancer Immunotherapy and Biomarkers (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (237 citations), Oncology (210 citations) and Hematology (74 citations). Eleonora Arboscello has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Paolo Spallarossa, Matteo Sarocchi, Pietro Ameri, Claudio Brunelli, Giacomo Tini, G Ghigliotti, Francesco Grossi, Giuseppina Novo, Gabriele Zoppoli and Manlio Mencoboni. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.